跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 229 条关于
“Leqembi IQLIK”
全部
229
临床试验
5
药物
1
机构
0
资讯
223
去年
FDA Approves Weekly Autoinjector for Eisai's Alzheimer's Drug Leqembi, Enabling At-Home Treatment
11个月前
Novo Nordisk's Semaglutide Fails in Alzheimer's Trials, Boosting Biogen's Leqembi Prospects
9个月前
LEQEMBI Shows Measurable Target Engagement with Alzheimer's Protofibrils in Cerebrospinal Fluid
3天前
Japan Approves LEQEMBI Pen, First At-Home Subcutaneous Alzheimer's Treatment
去年
EMA Approves Leqembi for Early-Stage Alzheimer's with Enhanced Monitoring
去年
EMA Approves Leqembi for Early-Stage Alzheimer's with Strict Monitoring
去年
CareMed Selected as National Pharmacy Partner for Alzheimer's Drug Leqembi
去年
Eisai and Biogen Seek Approval for Leqembi Autoinjector, Aiming for 2025 Launch
去年
Eisai and Biogen Pursue Subcutaneous Leqembi Approval for Alzheimer's
去年
EMA Expected to Decide on Leqembi Approval for Alzheimer's Treatment
第 1 页,共 23 页
上一页
下一页